Search

Filters

Clear Filters
5:17 PM - 5:32 PM PT

"From Diagnosis to Advocacy: A Patient's Journey to Transforming Cancer Education"
Speaker: Feldman, Jill, MA - EGFR Resisters, Deerfield, IL

. Simran, MBBS - All India Institute of Medical Sciences, Raipur, C.G

2:06 PM - 2:16 PM PT

1 - Primary Results from NRG-GU005: A Phase III Trial of SBRT vs. Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Speaker: Ellis, Rodney, MD - University South Florida and Tampa General Hospital Cancer Institute, Tampa, FL
2:30 PM - 2:40 PM PT

100 - Multicenter, Phase 3 Randomized Trial of Stereotactic Radiation vs. Hippocampal Avoidance Whole Brain Radiation in Patients with 5-20 Brain Metastases: Recurrence, Salvage Therapy, and Mortality Endpoints
Speaker: Aizer, Ayal, MD - Brigham and Women's Hospital, Boston, MA
8:05 AM - 8:10 AM PT

1000 - Second Pelvic Malignancies in Localized Prostate Cancer Treated with Radiotherapy: Long-Term Data from Two Phase III Trials
Speaker: Nabid, Abdenour, MD - CHUS, Sherbrooke, QC
8:10 AM - 8:15 AM PT

1001 - Optimizing Radiation Therapy for Prostate Cancer: Can Dose Reduction to the Pudendal Arteries Preserve Sexual Health?
Speaker: Kim-Wang, Sophia, MD, PhD - University of Chicago, Chicago, IL
8:15 AM - 8:20 AM PT

1002 - EPIC-26 Longitudinal Analyses of Prostatic Urethral Lift Implant with Stereotactic Ablative Body Radiotherapy for Men with Prostate Cancer and Benign Prostatic Hyperplasia
Speaker: Kwon, Young Suk, MD - University of Texas Southwestern Medical Center at Dallas, Dallas, TX
8:20 AM - 8:25 AM PT

1003 - Dosimetric Analysis of Post-Radiotherapy Sexual Dysfunction in Patients Receiving Definitive Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer: A Secondary Analysis of MIRAGE
Speaker: Massachi, Jonathan, MD, MS - University of California, Los Angeles, Los Angeles, CA
8:25 AM - 8:30 AM PT

1004 - Driving Improvement in Prostate Cancer Radiotherapy Outcomes through a National Quality Assurance Program: Results from a Large UK Academic Center
Speaker: Manik, Vishal, FRCR - Guys and St Thomas' NHS Foundation Trust, London, London
8:30 AM - 8:35 AM PT

1005 - Acute Toxicity Following Dose-Escalated MRI-Guided SBRT vs. Adapted Dose-Painted MRI-Guided SBRT: A Pooled Comparison of Prospective Trials
Speaker: Courtney, Patrick, MD, MAS - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles, CA
8:05 AM - 8:10 AM PT

1006 - Safety and Efficacy of an LED-Based Intraoral Device for Daily Photobiomodulation Therapy prior to Cancer Treatment for Reducing Severity of Oral Mucositis in Head and Neck Cancer Patients
Speaker: Hu, Kenneth Shung, MD, FASTRO - New York University, New York, NY
8:10 AM - 8:15 AM PT

1007 - A Randomized Controlled Trial of a New Symptom Management Model Based on PRO (Patient-Reported Outcomes) in Patients with Head and Neck Cancer Undergoing Radiotherapy
Speaker: Guo, Jing, BS - Xijing Hospital Air Force Medical University, Xi’an, Shaanxi